azithromycin (Q165399)

DrugBank

imported from Wikimedia project

17 November 2015

Azithromycin structure.svg
617 × 420; 76 KB

1 reference

German Wikipedia

Azithromycin.png
1,878 × 1,302; 40 KB

0 references

image of molecular model or crystal lattice model

Azithromycin 3d structure.png
1,399 × 1,268; 420 KB

depicts

ball-and-stick model

0 references

pronunciation audio

LL-Q33810 (ori)-Psubhashish-ଆଜିଥ୍ରୋମାଇସିନ.wav
1.7 s; 163 KB

Odia

1 reference

https://lingualibre.org/wiki/Q636536

mass

748.509 dalton

1 reference

azithromycin (English)

18 November 2016

chemical formula

C₃₈H₇₂N₂O₁₂

1 reference

azithromycin (English)

18 November 2016

canonical SMILES

CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O

1 reference

azithromycin (English)

18 November 2016

isomeric SMILES

CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O

1 reference

azithromycin (English)

World Health Organisation international non-proprietary name

18 November 2016

Azithromycin (English)

1 reference

Azithromycin (English)

medical condition treated

19 January 2016

2 references

13 December 2016

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

2 references

13 December 2016

upper respiratory tract infection

2 October 2018

1 reference

13 December 2016

2 references

13 December 2016

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

staphylococcal infection

1 reference

13 December 2016

1 reference

2 October 2018

lung disease

1 reference

bacterial infectious disease

2 October 2018

1 reference

2 October 2018

nasopharyngitis

1 reference

2 October 2018

pneumonia

1 reference

2 October 2018

otitis

1 reference

Mycobacterium avium-intracellulare infection

2 October 2018

1 reference

susceptibility to severe influenza

2 October 2018

1 reference

2 October 2018

blepharitis

1 reference

2 October 2018

bronchiolitis obliterans

1 reference

2 October 2018

1 November 1991

1 reference

2 November 2018

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050710s043,050711s040,050784s027lbl.pdf

urethritis

start time

1 November 1991

approved by

1 reference

2 November 2018

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050710s043,050711s040,050784s027lbl.pdf

otitis media

start time

1 November 1991

approved by

1 reference

2 November 2018

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050710s043,050711s040,050784s027lbl.pdf

pneumonia

start time

1 November 1991

approved by

1 reference

2 November 2018

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050710s043,050711s040,050784s027lbl.pdf

COVID-19

1 reference

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

significant drug interaction

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

clarithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

amiodarone

1 reference

High-priority drug–drug interactions for use in electronic health records

anagrelide

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

chlorpromazine

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

disopyramide

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

droperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

erythromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

haloperidol

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-methadone

1 reference

High-priority drug–drug interactions for use in electronic health records

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

pentamidine

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

sotalol

1 reference

High-priority drug–drug interactions for use in electronic health records

sparfloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-sulpiride

1 reference

High-priority drug–drug interactions for use in electronic health records

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

digoxin

side effect

heart arrhythmia

1 reference

sourcing circumstances

probably

A reference set of clinically relevant adverse drug-drug interactions

digoxin

side effect

vomiting

1 reference

sourcing circumstances

probably

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6510

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B1

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category B

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category A

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Azithromycin

8 August 2017

1 reference

https://www.pfizer.com/products/product-list

subject has role

protein synthesis inhibitor

1 reference

5 March 2018

1 reference

Medical Subject Headings

15 March 2018

0 references

1 reference

‎WHO Aware Classification

watch

1 reference

2023 ‎AWaRe classification‎

Commons category

Azithromycin

0 references

Identifiers

InChI

InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1

1 reference

azithromycin (English)

MQTOSJVFKKJCRP-BICOPXKESA-N

18 November 2016

InChIKey

2 references

azithromycin (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

83905-01-5

2 references

Global Substance Registration System

UNII

J2KLZ20U1M

azithromycin anhydrous (English)

MQTOSJVFKKJCRP-BICOPXKESA-N

18 November 2016

InChIKey

9 April 2021

https://commonchemistry.cas.org/detail?cas_rn=83905-01-5

1 reference

Azithromycin (English)

18 November 2016

1 reference

azithromycin (English)

18 November 2016

Reaxys registry number

8820027

1 reference

azithromycin (English)

19 October 2016

5387583

1 reference

azithromycin (English)

19 October 2016

ChEBI ID

2955

mapping relation type

2 references

AZITHROMYCIN (English)

18 November 2016

ChEBI release 2019-10-02

1 reference

MSBNK-Athens_Univ-AU105202

AZITHROMYCIN (English)

18 November 2016

1 reference

MassBank accession ID

0 references

SPLASH

splash10-0f6t-0300030900-1a7ea512a0aa566e59ed

0 references

splash10-066r-4911100000-f759f24274aebce8e08c

0 references

splash10-052f-3912280200-df9a72a4769570064ef9

0 references

HSDB ID

7205

1 reference

Hazardous Substances Data Bank

28 October 2019

AZITHROMYCIN (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

617-500-5

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.126.551

27 December 2018

ECHA Substance Infocard ID

2R,3R,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one (English)

quotation

CAS no.: 83905-01-5 (English)

100.126.551

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.126.551

27 December 2018

2R,3R,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one (English)

quotation

CAS no.: 83905-01-5 (English)

1 reference